Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous vascular hemostasis device for interventional procedures.

A Merino1, C Faulkner, A Corvalan

  • 1Department of Medicine, Mount Sinai Medical Center, New York.

Catheterization and Cardiovascular Diagnosis
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence of canine intestinal parasites and associated fecal bacteria among urban and rural dog parks in central Appalachia U.S.

Veterinary parasitology, regional studies and reports·2025
Same author

Fire enhances changes in phosphorus (P) dynamics determining potential post-fire soil recovery in Mediterranean woodlands.

Scientific reports·2024
Same author

Creating a kidney organoid-vasculature interaction model using a novel organ-on-chip system.

Scientific reports·2022
Same author

Bio-distribution and longevity of mesenchymal stromal cell derived membrane particles.

Journal of controlled release : official journal of the Controlled Release Society·2022
Same author

A Review of the EUSO-Balloon Pathfinder for the JEM-EUSO Program.

Space science reviews·2022
Same author

Can straw-biochar mulching mitigate erosion of wildfire-degraded soils under extreme rainfall?

The Science of the total environment·2020
Same journal

Balloon mitral valvuloplasty: double vs single transseptal puncture.

Catheterization and cardiovascular diagnosis·1998
Same journal

Early experience with the Bard XT stent.

Catheterization and cardiovascular diagnosis·1998
Same journal

Bifurcation stenting: the task ahead.

Catheterization and cardiovascular diagnosis·1998
Same journal

Protection of side-branches in coronary lesions with a new stent design.

Catheterization and cardiovascular diagnosis·1998
Same journal

Subselective opacification of a left internal mammary artery graft in a tortuous subclavian artery: use of angioplasty technique and a Tracker catheter.

Catheterization and cardiovascular diagnosis·1998
Same journal

Imaging factors and image optimization.

Catheterization and cardiovascular diagnosis·1998
See all related articles

A novel vascular hemostasis device offers a safe and effective alternative to manual compression for achieving arterial puncture site closure. This new device significantly reduces compression time and complications, ensuring normal arterial healing.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Biomaterials

Background:

  • Achieving effective hemostasis after percutaneous arterial access remains a critical challenge.
  • Conventional manual compression is time-consuming and associated with complications like hematoma.
  • Minimally invasive techniques are sought to improve safety and efficiency in vascular procedures.

Purpose of the Study:

  • To evaluate the safety and efficacy of a new 11.5F over-the-wire vascular hemostasis device.
  • To compare the device's performance against conventional manual compression in swine femoral arteries.
  • To assess long-term arterial healing and patency after device deployment.

Main Methods:

  • A prospective study comparing a novel collagen-based hemostasis device with manual compression.

Related Experiment Videos

  • Percutaneous deployment of the device in swine femoral arteries.
  • Assessment of hemostasis time, complications (hematoma), and histological analysis at one-month follow-up.

    • Main Results:

    • Hemostasis was achieved rapidly with the device (1 minute total + 4 minutes partial compression).
    • Manual compression required over 5 minutes to avoid hematoma formation.
    • One-month follow-up revealed no impairment in distal pulse or significant histological differences between device-treated and control arteries.

    Conclusions:

    • The novel vascular hemostasis device is safe and effective for achieving rapid arterial closure.
    • The device significantly reduces compression time and lowers the risk of complications compared to manual compression.
    • The technique does not compromise arterial wall healing or lumen patency, supporting its clinical utility.